Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years (2016)
- Authors:
- USP affiliated authors: OSORIO, FLAVIA DE LIMA - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1177/2045125316638008
- Subjects: PLANTAS ALUCINÓGENAS; ALUCINOGÊNICOS; ANTIDEPRESSIVOS; ANSIOLÍTICOS; FARMACOLOGIA; REVISÃO SISTEMÁTICA
- Keywords: Ayahuasca; Dimethyltryptamine; Hallucinogens; LSD; Psilocybin; Tryptamines
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Therapeutic Advances in Psychopharmacology
- ISSN: 2045-1253
- Volume/Número/Paginação/Ano: v. 6, n. 3, p. 193-213, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
SANTOS, Rafael G. dos et al. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology, v. 6, n. 3, p. 193-213, 2016Tradução . . Disponível em: https://doi.org/10.1177/2045125316638008. Acesso em: 04 maio 2024. -
APA
Santos, R. G. dos, Osório, F. de L., Crippa, J. A. de S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016). Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology, 6( 3), 193-213. doi:10.1177/2045125316638008 -
NLM
Santos RG dos, Osório F de L, Crippa JA de S, Riba J, Zuardi AW, Hallak JEC. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years [Internet]. Therapeutic Advances in Psychopharmacology. 2016 ; 6( 3): 193-213.[citado 2024 maio 04 ] Available from: https://doi.org/10.1177/2045125316638008 -
Vancouver
Santos RG dos, Osório F de L, Crippa JA de S, Riba J, Zuardi AW, Hallak JEC. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years [Internet]. Therapeutic Advances in Psychopharmacology. 2016 ; 6( 3): 193-213.[citado 2024 maio 04 ] Available from: https://doi.org/10.1177/2045125316638008 - Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder: a case report
- Classical hallucinogens and neuroimaging: a systematic review of human studies studies : hallucinogens and neuroimaging
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
Informações sobre o DOI: 10.1177/2045125316638008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
